Motley Fool Money cover image

Selling Secrets Across The Globe

Motley Fool Money

Vertex Pharmaceuticals' Virtual Monopoly for Cystic Fibrosis

5min Snip

00:00
Play full episode
Ricky Mulvey and Motley Fool analyst Kirsten Gura dive into a biotech company that owns a virtual monopoly for a life-changing treatment. You can't innovate and generate solid free cash flow without innovating, they say. How do you think about regulatory risk in vertic Pharmaceuticals? We'll have to wait and see what happens with this one.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode